Tag: Novartis

Novartis logo

Breaking News: FDA Approves Treatment for pNET Patients

May 5, 2011

For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients!  The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients.  This is a milestone for the carcinoid/NET…

READ MORE
novartis-oncology-logo

Carcinoid Cancer Foundation Thanks Symposium Sponsors

April 21, 2011

There’s still time to register for the Carcinoid Cancer Foundation’s 14th annual  symposium for patients, family, friends, and healthcare professionals, which will be held on Sunday, May 1st at Mount Sinai Medical Center in New York City.  The Foundation…

READ MORE
CNETS Halifax 2011 Conference

CNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals

April 1, 2011

Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…

READ MORE
FDA logo

Carcinoid Cancer Foundation to Speak on Behalf of NET Cancer Patients at April 12, 2011 FDA Oncologic Drugs Advisory Committee Meeting

March 24, 2011

Grace Goldstein, Chief Operating Officer of the Carcinoid Cancer Foundation, will speak at the Open Public Hearing segment during the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee Meeting on April 12, 2011 in Silver …

READ MORE
iWalk for Carcinoid

iWalk for Carcinoid

September 25, 2010

iWalk for Carcinoid is a virtual walkathon to help raise money for carcinoid-related organizations. The Carcinoid Cancer Foundation is one of the organizations selected to benefit from this virtual walkathon.  Each organization has the opportunity…

READ MORE
Sanofi_GoMeals_iPhone_app

12 iPhone Apps for Patients and Physicians

July 27, 2010

For carcinoid and neuroendocrine cancer iPhone users there are many resources for you as a patient or for your physician that have been created by big pharmaceutical companies around the world.  These pharma companies include Novartis, Pfizer, Merck

READ MORE

Sandostatin Mobile Administration Program for Carcinoid Syndrome Patients

February 18, 2010

If you are a carcinoid patient who needs Sandostatin® LAR Depot injections, you may be eligible for the Mobile Administration Program.  This program helps alleviate the stress of driving to a doctor’s office (or finding one where you live or while on vacation),…

READ MORE
2009 Kenner Conference Logo

Video Recording of National Carcinoid Cancer and Neuroendocrine Tumor Patient Conference Now Online

January 19, 2010

Whether you are newly diagnosed with carcinoid cancer or another neuroendocrine tumor or you are seeking novel treatments for NETs you can gain invaluable information from the video recording of the 2009 National Carcinoid/NET Patient Conference

READ MORE